Programmed Death Ligand 1 (PD-L1) Expression in Primary Angiosarcoma
Gerardo Botti(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Annarosaria De Chiara(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale")
Cited by 51
Related Papers
Programmed Death Ligand 1 (PD-L1) Tumor Expression Is Associated with a Better Prognosis and Diabetic Disease in Triple Negative Breast Cancer Patients
|International Journal of Molecular Sciences|2017|112
Increased HOX C13 expression in metastatic melanoma progression
|Journal of Translational Medicine|2012|43